
My Diabetes Health
OperatingMy Diabetes Health, Inc.
Healthcare · Wilmington, DE
My Diabetes Health delivers insurance-covered telehealth diabetes education nationwide, having served 8,600+ patients with clinically significant results.
Financials
FY2023–FY2024 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps markedA dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Team
8 people
Dr. Prem Sahasranam, who goes by Dr. Sahas, is a Board-Certified Endocrinologist and Founder of My Diabetes Health, with over 20 years of experience caring for individuals with diabetes. He is also a faculty member at Loma Linda University School of Medicine, Loma Linda, CA.


Dren Radoniqi is a finance executive with more than 18 years of experience in financial leadership, corporate development, and transaction execution across private equity-backed and high-growth companies. Prior to joining My Diabetes Tutor as Chief Financial Officer, he spent 15 years in senior leadership roles at EY, advising private equity firms, portfolio companies, and multinational enterprises across the healthcare, technology, and energy sectors. Following EY, he served as a Strategic Advisor and Chief Financial Officer to several global technology and artificial intelligence companies, working closely with founders and investors on mergers and acquisitions, capital strategy, and enterprise value creation initiatives.

Mr. Woodward is a partner and co-founder of Woodward Diversified Capital, a family wealth management and private equity investment firm, founded in March 2020. Prior to co-founding WDC, Mr. Woodward worked from March of 2005 thru March of 2020 at Bank of America and Wells Fargo where he spent the final years as a SVP-Private Wealth Advisor. Mr. Woodward has served on the board of numerous companies and non-profits in the past, including Genelux Corporation (GNLX) where he served during its IPO. In addition to My Diabetes Tutor, Mr. Woodward currently serves on the boards of Aeromics, a Thousand Oaks, CA, based clinical trial stage stroke therapeutics company, and Fundare Resources, a Denver, CO based oil and gas company. Mr. Woodward and his wife, Staci, have owned The Bakersfield Swim Academy since 2012. Mr. Woodward is a former competitive swimmer for Team USA. Mr. Woodward holds a B.A. in social sciences with an emphasis in History from The University of Southern California.

Neel Patel is CEO and Founder of OM Pacific Capital, a Multi-Family Office. He started the firm in 2015. They manage a significant amount of capital for 30 families including his own family, across all asset classes including Equities, Fixed Income, Hedge Funds, Private Equity, Real Estate, Crypto, Venture Capital and Private Credit. Neel started to invest directly in venture backed companies starting in 2015 through their Venture Capital Arm of his firm. They invest at seed and Series A. Sectors include: Technology, i.e. saas companies, artificial Intelligence, Healthcare/Health-tech, Real Estate Tech and Fin-tech. Some of the companies they have invested in are: Snowflake (IPO’d), Guardant Health (IPO’d), Coinbase (IPO’d), Whiterabbit.ai (still private), and Zoom (IPO’d) to name a few. Neel spent 10 years at Merrill Lynch in their ultra high net worth group and Institutional division. These prior investments are independent of My Diabetes Health and do not reflect or predict any potential return on this offering.

Sharon Chandran began her career in Oil & Gas. Over a decade, she held various managerial roles, culminating as Executive Director of a publicly listed company in Singapore. She currently is CEO of her family office, overseeing a myriad of investments across multiple industries and asset classes.
Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
Filed 0 of 1 annual reports (FY2025)
Missing: 2025
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.